Agreed, they don't have very good info on dosage levels and frequency it seems. They have some limited references from Phase I and maybe GR-MD-02 works, but just not in the structure on the FX trial.
Not sure if they are, but finding a partner to explore this further and for other fibrosis indications seems like it would make sense.
News 
Market Data 
Discover 
